Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
Axol Bioscience acquires Phenocell to advance human disease models
21 October 2024
Guest User
Axol Bioscience acquires Phenocell to advance human disease models
Guest User
21 October 2024

Axol Bioscience acquires Phenocell to advance human disease models

Guest User
21 October 2024

Source:https://axolbio.com/axol-bioscience-acquires-phenocell-to-advance-human-disease-models/

Newer PostDeepHealth Strengthens AI Breast Cancer Screening Position with Kheiron Acquisition
Older Post10 Cambridge spinouts changing the story of cancer
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net